1. Home
  2. VYX vs BVS Comparison

VYX vs BVS Comparison

Compare VYX & BVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NCR Voyix Corporation

VYX

NCR Voyix Corporation

N/A

Current Price

$9.28

Market Cap

994.1M

Sector

N/A

ML Signal

N/A

Logo Bioventus Inc.

BVS

Bioventus Inc.

N/A

Current Price

$9.88

Market Cap

910.2M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
VYX
BVS
Founded
1881
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
994.1M
910.2M
IPO Year
1996
2016

Fundamental Metrics

Financial Performance
Metric
VYX
BVS
Price
$9.28
$9.88
Analyst Decision
Buy
Strong Buy
Analyst Count
7
5
Target Price
$13.29
★ $16.60
AVG Volume (30 Days)
★ 2.8M
625.9K
Earning Date
11-05-2026
11-02-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 163.46
EPS
0.09
★ 0.60
Revenue
★ $7,156,000,000.00
$568,087,000.00
Revenue This Year
N/A
$4.72
Revenue Next Year
N/A
$6.41
P/E Ratio
$105.33
★ $16.59
Revenue Growth
★ 15.29
N/A
52 Week Low
$6.02
$7.02
52 Week High
$11.31
$15.89

Technical Indicators

Market Signals
Indicator
VYX
BVS
Relative Strength Index (RSI) 50.85 28.59
Support Level $6.46 $9.82
Resistance Level $9.32 $11.00
Average True Range (ATR) 0.63 0.61
MACD -0.09 -0.13
Stochastic Oscillator 28.60 3.07

Price Performance

Historical Comparison
VYX
BVS

About VYX NCR Voyix Corporation

NCR Voyix Corp is a company providing services of digital commerce solutions for retail, restaurant, and digital banking. The company operates in two reportable segments: Retail, and Restaurants. The Retail segment provides software solutions for retailers of all sizes, enhancing operational efficiency and customer experience. The Restaurants segment offers end-to-end technology solutions for food service establishments, improving operational efficiency, and customer satisfaction, and reducing costs. The company derives maximum revenue from Retail segment. Geographically, the company operates in United States, Americas (excluding United States), Europe, Middle East and Africa, and Asia Pacific. It derives maximum revenue from United States.

About BVS Bioventus Inc.

Bioventus Inc is a medical device company focused on developing and commercializing products to relieve pain and address musculoskeletal conditions. The company operates through two reporting segments, U.S. and International, and its product portfolio is organized into three main business areas: Pain Treatments, Surgical Solutions, and Restorative Therapies, offering products such as hyaluronic acid injections for osteoarthritis, peripheral nerve stimulation devices, bone graft substitutes, and ultrasound-based fracture healing therapies.

Share on Social Networks: